Correction: Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial - Top-Institutions - MDSpire

Correction: Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial

  • By

  • Joris Vangeneugden

  • Saar Vermijs

  • Peter De Kuyper

  • Camille Berquin

  • Nicolaas Lumen

  • Victor Declerck

  • Frederic Baekelandt

  • Christophe Ghysel

  • Yannic Raskin

  • Bernard Bynens

  • Kenzo Mestdagh

  • Pieter De Backer

  • Pieter De Visschere

  • Charlotte Debbaut

  • Charles Van Praet

  • Karel Decaestecker

  • July 17, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Urology
    • Oncology

  • #2

    NYU Langone Health
    NYU Langone Health

    New York, New York

    Key Differentiators

    • Urology
    • Oncology

  • #3

    Hiroshima University
    Hiroshima University

    Hiroshima, Hiroshima

    Key Differentiators

    • Urology

  • #4

    First Affiliated Hospital of Naval Medical University
    First Affiliated Hospital of Naval Medical University

    Shanghai, Shanghai

    Key Differentiators

    • Urology

  • #5

    University of Illinois at Chicago
    University of Illinois at Chicago

    Chicago, Illinois

    Key Differentiators

    • Urology

Original Source(s)

Correction: Transperitoneal versus retroperitoneal approach does not alter arterial clamping strategy during robot-assisted partial nephrectomy: interim results from the multicentric PODRACING randomized controlled trial

  • by Joris Vangeneugden, Saar Vermijs, Peter De Kuyper, Camille Berquin, Nicolaas Lumen, Victor Declerck, Frederic Baekelandt, Christophe Ghysel, Yannic Raskin, Bernard Bynens, Kenzo Mestdagh, Pieter De Backer, Pieter De Visschere, Charlotte Debbaut, Charles Van Praet, Karel Decaestecker

  • July 17, 2026

Related Content

The dual role of parasites and parasite-derived products in cancer biology: a systematic review of in vitro and in vivo evidence

A machine learning-based prognostic model for de novo metastatic HR-positive breast cancer: SEER cohort with external validation

Combined therapy strategies of immune checkpoint inhibitors in gynecologic oncology: progress and challenges